Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT05261399 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 324 participants |
| Active Locations | 13 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 10, 2025 (Jan 10, 2025) |
As of March 2, 2026: Clinical trial NCT05261399 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05261399 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05261399 was last updated Jan 10, 2025 (January 10, 2025). HelloStudys verifies this status automatically.